#FORMAT=WebAnno TSV 3.2
#T_SP=webanno.custom.Diy_coref|
#T_RL=webanno.custom.Diy_coref_re|BT_webanno.custom.Diy_coref


#Text=[0011]Programming of the pulse generators, or implants, can be divided into two main programming categories: (1) programming of stimulation pulse variables, and (2) programming electrode configurations.
1-1	0-1	[	_	_	
1-2	1-5	0011	_	_	
1-3	5-6	]	_	_	
1-4	6-17	Programming	_	_	
1-5	18-20	of	_	_	
1-6	21-24	the	_	_	
1-7	25-30	pulse	_	_	
1-8	31-41	generators	_	_	
1-9	41-42	,	_	_	
1-10	43-45	or	_	_	
1-11	46-54	implants	_	_	
1-12	54-55	,	_	_	
1-13	56-59	can	_	_	
1-14	60-62	be	_	_	
1-15	63-70	divided	_	_	
1-16	71-75	into	_	_	
1-17	76-79	two	_	_	
1-18	80-84	main	_	_	
1-19	85-96	programming	_	_	
1-20	97-107	categories	_	_	
1-21	107-108	:	_	_	
1-22	109-110	(	_	_	
1-23	110-111	1	_	_	
1-24	111-112	)	_	_	
1-25	113-124	programming	_	_	
1-26	125-127	of	_	_	
1-27	128-139	stimulation	_	_	
1-28	140-145	pulse	_	_	
1-29	146-155	variables	_	_	
1-30	155-156	,	_	_	
1-31	157-160	and	_	_	
1-32	161-162	(	_	_	
1-33	162-163	2	_	_	
1-34	163-164	)	_	_	
1-35	165-176	programming	_	_	
1-36	177-186	electrode	_	_	
1-37	187-201	configurations	_	_	
1-38	201-202	.	_	_	

#Text=Programmable stimulation pulse variables, as previously indicated, typically include pulse amplitude, pulse duration, pulse repetition rate, burst rate, and the like.
2-1	203-215	Programmable	_	_	
2-2	216-227	stimulation	_	_	
2-3	228-233	pulse	_	_	
2-4	234-243	variables	_	_	
2-5	243-244	,	_	_	
2-6	245-247	as	_	_	
2-7	248-258	previously	_	_	
2-8	259-268	indicated	_	_	
2-9	268-269	,	_	_	
2-10	270-279	typically	_	_	
2-11	280-287	include	_	_	
2-12	288-293	pulse	_	_	
2-13	294-303	amplitude	_	_	
2-14	303-304	,	_	_	
2-15	305-310	pulse	_	_	
2-16	311-319	duration	_	_	
2-17	319-320	,	_	_	
2-18	321-326	pulse	_	_	
2-19	327-337	repetition	_	_	
2-20	338-342	rate	_	_	
2-21	342-343	,	_	_	
2-22	344-349	burst	_	_	
2-23	350-354	rate	_	_	
2-24	354-355	,	_	_	
2-25	356-359	and	_	_	
2-26	360-363	the	_	_	
2-27	364-368	like	_	_	
2-28	368-369	.	_	_	

#Text=Programmable electrode configuration includes the selection of electrodes for simulation from the available electrode contacts within the array as well as electrode polarity (+/-) assignments.
3-1	370-382	Programmable	_	_	
3-2	383-392	electrode	_	_	
3-3	393-406	configuration	_	_	
3-4	407-415	includes	_	_	
3-5	416-419	the	_	_	
3-6	420-429	selection	_	_	
3-7	430-432	of	_	_	
3-8	433-443	electrodes	_	_	
3-9	444-447	for	_	_	
3-10	448-458	simulation	_	_	
3-11	459-463	from	_	_	
3-12	464-467	the	_	_	
3-13	468-477	available	_	_	
3-14	478-487	electrode	_	_	
3-15	488-496	contacts	_	_	
3-16	497-503	within	_	_	
3-17	504-507	the	_	_	
3-18	508-513	array	_	_	
3-19	514-516	as	_	_	
3-20	517-521	well	_	_	
3-21	522-524	as	_	_	
3-22	525-534	electrode	_	_	
3-23	535-543	polarity	_	_	
3-24	544-545	(	_	_	
3-25	545-546	+	_	_	
3-26	546-547	/	_	_	
3-27	547-548	-	_	_	
3-28	548-549	)	_	_	
3-29	550-561	assignments	_	_	
3-30	561-562	.	_	_	

#Text=Factors to consider when programming an electrode configuration include the number of electrode contacts to be selected, the polarity assigned to each selected electrode contact, and the location of each selected electrode contact within the array relative to the spinal cord, and the distance between selected electrodes (anodes and cathodes), all of which factors combine to define a stimulation field.
4-1	563-570	Factors	_	_	
4-2	571-573	to	_	_	
4-3	574-582	consider	_	_	
4-4	583-587	when	_	_	
4-5	588-599	programming	_	_	
4-6	600-602	an	_	_	
4-7	603-612	electrode	_	_	
4-8	613-626	configuration	_	_	
4-9	627-634	include	_	_	
4-10	635-638	the	_	_	
4-11	639-645	number	_	_	
4-12	646-648	of	_	_	
4-13	649-658	electrode	_	_	
4-14	659-667	contacts	_	_	
4-15	668-670	to	_	_	
4-16	671-673	be	_	_	
4-17	674-682	selected	_	_	
4-18	682-683	,	_	_	
4-19	684-687	the	_	_	
4-20	688-696	polarity	_	_	
4-21	697-705	assigned	_	_	
4-22	706-708	to	_	_	
4-23	709-713	each	_	_	
4-24	714-722	selected	_	_	
4-25	723-732	electrode	_	_	
4-26	733-740	contact	_	_	
4-27	740-741	,	_	_	
4-28	742-745	and	_	_	
4-29	746-749	the	_	_	
4-30	750-758	location	_	_	
4-31	759-761	of	_	_	
4-32	762-766	each	_	_	
4-33	767-775	selected	_	_	
4-34	776-785	electrode	_	_	
4-35	786-793	contact	_	_	
4-36	794-800	within	_	_	
4-37	801-804	the	_	_	
4-38	805-810	array	_	_	
4-39	811-819	relative	_	_	
4-40	820-822	to	_	_	
4-41	823-826	the	_	_	
4-42	827-833	spinal	_	_	
4-43	834-838	cord	_	_	
4-44	838-839	,	_	_	
4-45	840-843	and	_	_	
4-46	844-847	the	_	_	
4-47	848-856	distance	_	_	
4-48	857-864	between	_	_	
4-49	865-873	selected	_	_	
4-50	874-884	electrodes	_	_	
4-51	885-886	(	_	_	
4-52	886-892	anodes	_	_	
4-53	893-896	and	_	_	
4-54	897-905	cathodes	_	_	
4-55	905-906	)	_	_	
4-56	906-907	,	_	_	
4-57	908-911	all	_	_	
4-58	912-914	of	_	_	
4-59	915-920	which	_	_	
4-60	921-928	factors	_	_	
4-61	929-936	combine	_	_	
4-62	937-939	to	_	_	
4-63	940-946	define	_	_	
4-64	947-948	a	_	_	
4-65	949-960	stimulation	_	_	
4-66	961-966	field	_	_	
4-67	966-967	.	_	_	

#Text=The clinician's electrode selection results in a simulating "group" containing at least one anode and at least one cathode that can be used to pass stimulating currents defined by the programmed pulse variables.
5-1	968-971	The	_	_	
5-2	972-983	clinician's	_	_	
5-3	984-993	electrode	_	_	
5-4	994-1003	selection	_	_	
5-5	1004-1011	results	_	_	
5-6	1012-1014	in	_	_	
5-7	1015-1016	a	_	_	
5-8	1017-1027	simulating	_	_	
5-9	1028-1029	"	_	_	
5-10	1029-1034	group	_	_	
5-11	1034-1035	"	_	_	
5-12	1036-1046	containing	_	_	
5-13	1047-1049	at	_	_	
5-14	1050-1055	least	_	_	
5-15	1056-1059	one	_	_	
5-16	1060-1065	anode	_	_	
5-17	1066-1069	and	_	_	
5-18	1070-1072	at	_	_	
5-19	1073-1078	least	_	_	
5-20	1079-1082	one	_	_	
5-21	1083-1090	cathode	_	_	
5-22	1091-1095	that	_	_	
5-23	1096-1099	can	_	_	
5-24	1100-1102	be	_	_	
5-25	1103-1107	used	_	_	
5-26	1108-1110	to	_	_	
5-27	1111-1115	pass	_	_	
5-28	1116-1127	stimulating	_	_	
5-29	1128-1136	currents	_	_	
5-30	1137-1144	defined	_	_	
5-31	1145-1147	by	_	_	
5-32	1148-1151	the	_	_	
5-33	1152-1162	programmed	_	_	
5-34	1163-1168	pulse	_	_	
5-35	1169-1178	variables	_	_	
5-36	1178-1179	.	_	_	

#Text=For an electrode array having eight electrode contacts, this can result in an unreasonable large number of possible combinations, or stimulation groups, to chose from.
#Text=[0012]Moreover, within each stimulation group, there are a large number of pulse stimulation parameters that may be selected.
6-1	1180-1183	For	_	_	
6-2	1184-1186	an	_	_	
6-3	1187-1196	electrode	_	_	
6-4	1197-1202	array	_	_	
6-5	1203-1209	having	_	_	
6-6	1210-1215	eight	_	_	
6-7	1216-1225	electrode	_	_	
6-8	1226-1234	contacts	_	_	
6-9	1234-1235	,	_	_	
6-10	1236-1240	this	_	_	
6-11	1241-1244	can	_	_	
6-12	1245-1251	result	_	_	
6-13	1252-1254	in	_	_	
6-14	1255-1257	an	_	_	
6-15	1258-1270	unreasonable	_	_	
6-16	1271-1276	large	_	_	
6-17	1277-1283	number	_	_	
6-18	1284-1286	of	_	_	
6-19	1287-1295	possible	_	_	
6-20	1296-1308	combinations	_	_	
6-21	1308-1309	,	_	_	
6-22	1310-1312	or	_	_	
6-23	1313-1324	stimulation	_	_	
6-24	1325-1331	groups	_	_	
6-25	1331-1332	,	_	_	
6-26	1333-1335	to	_	_	
6-27	1336-1341	chose	_	_	
6-28	1342-1346	from	_	_	
6-29	1346-1347	.	_	_	
6-30	1348-1349	[	_	_	
6-31	1349-1353	0012	_	_	
6-32	1353-1354	]	_	_	
6-33	1354-1362	Moreover	_	_	
6-34	1362-1363	,	_	_	
6-35	1364-1370	within	_	_	
6-36	1371-1375	each	_	_	
6-37	1376-1387	stimulation	_	_	
6-38	1388-1393	group	_	_	
6-39	1393-1394	,	_	_	
6-40	1395-1400	there	_	_	
6-41	1401-1404	are	_	_	
6-42	1405-1406	a	_	_	
6-43	1407-1412	large	_	_	
6-44	1413-1419	number	_	_	
6-45	1420-1422	of	_	_	
6-46	1423-1428	pulse	_	_	
6-47	1429-1440	stimulation	_	_	
6-48	1441-1451	parameters	_	_	
6-49	1452-1456	that	_	_	
6-50	1457-1460	may	_	_	
6-51	1461-1463	be	_	_	
6-52	1464-1472	selected	_	_	
6-53	1472-1473	.	_	_	

#Text=Thus, through the programmer, the clinician must select each electrode, including polarity, for stimulation to create each combination of electrode contacts for patient testing.
7-1	1474-1478	Thus	_	_	
7-2	1478-1479	,	_	_	
7-3	1480-1487	through	_	_	
7-4	1488-1491	the	_	_	
7-5	1492-1502	programmer	_	_	
7-6	1502-1503	,	_	_	
7-7	1504-1507	the	_	_	
7-8	1508-1517	clinician	_	_	
7-9	1518-1522	must	_	_	
7-10	1523-1529	select	_	_	
7-11	1530-1534	each	_	_	
7-12	1535-1544	electrode	_	_	
7-13	1544-1545	,	_	_	
7-14	1546-1555	including	_	_	
7-15	1556-1564	polarity	_	_	
7-16	1564-1565	,	_	_	
7-17	1566-1569	for	_	_	
7-18	1570-1581	stimulation	_	_	
7-19	1582-1584	to	_	_	
7-20	1585-1591	create	_	_	
7-21	1592-1596	each	_	_	
7-22	1597-1608	combination	_	_	
7-23	1609-1611	of	_	_	
7-24	1612-1621	electrode	_	_	
7-25	1622-1630	contacts	_	_	
7-26	1631-1634	for	_	_	
7-27	1635-1642	patient	_	_	
7-28	1643-1650	testing	_	_	
7-29	1650-1651	.	_	_	

#Text=Then, for each combination, the clinician adjusts the stimulation parameters for patient feedback until the optimal pain relief is found for the patient.
8-1	1652-1656	Then	_	_	
8-2	1656-1657	,	_	_	
8-3	1658-1661	for	_	_	
8-4	1662-1666	each	_	_	
8-5	1667-1678	combination	_	_	
8-6	1678-1679	,	_	_	
8-7	1680-1683	the	_	_	
8-8	1684-1693	clinician	_	_	
8-9	1694-1701	adjusts	_	_	
8-10	1702-1705	the	_	_	
8-11	1706-1717	stimulation	_	_	
8-12	1718-1728	parameters	_	_	
8-13	1729-1732	for	_	_	
8-14	1733-1740	patient	_	_	
8-15	1741-1749	feedback	_	_	
8-16	1750-1755	until	_	_	
8-17	1756-1759	the	_	_	
8-18	1760-1767	optimal	_	_	
8-19	1768-1772	pain	_	_	
8-20	1773-1779	relief	_	_	
8-21	1780-1782	is	_	_	
8-22	1783-1788	found	_	_	
8-23	1789-1792	for	_	_	
8-24	1793-1796	the	_	_	
8-25	1797-1804	patient	_	_	
8-26	1804-1805	.	_	_	

#Text=Disadvantageously, it is difficult to test many stimulation variables with hundreds or even thousands of possible electrode and stimulus parameter combinations.
9-1	1806-1823	Disadvantageously	_	_	
9-2	1823-1824	,	_	_	
9-3	1825-1827	it	_	_	
9-4	1828-1830	is	_	_	
9-5	1831-1840	difficult	_	_	
9-6	1841-1843	to	_	_	
9-7	1844-1848	test	_	_	
9-8	1849-1853	many	_	_	
9-9	1854-1865	stimulation	_	_	
9-10	1866-1875	variables	_	_	
9-11	1876-1880	with	_	_	
9-12	1881-1889	hundreds	_	_	
9-13	1890-1892	or	_	_	
9-14	1893-1897	even	_	_	
9-15	1898-1907	thousands	_	_	
9-16	1908-1910	of	_	_	
9-17	1911-1919	possible	_	_	
9-18	1920-1929	electrode	_	_	
9-19	1930-1933	and	_	_	
9-20	1934-1942	stimulus	_	_	
9-21	1943-1952	parameter	_	_	
9-22	1953-1965	combinations	_	_	
9-23	1965-1966	.	_	_	

#Text=To test all such combinations, which is typically necessary in order to find the optimum stimulation settings, is a very lengthy and tedious process.
10-1	1967-1969	To	_	_	
10-2	1970-1974	test	_	_	
10-3	1975-1978	all	_	_	
10-4	1979-1983	such	_	_	
10-5	1984-1996	combinations	_	_	
10-6	1996-1997	,	_	_	
10-7	1998-2003	which	_	_	
10-8	2004-2006	is	_	_	
10-9	2007-2016	typically	_	_	
10-10	2017-2026	necessary	_	_	
10-11	2027-2029	in	_	_	
10-12	2030-2035	order	_	_	
10-13	2036-2038	to	_	_	
10-14	2039-2043	find	_	_	
10-15	2044-2047	the	_	_	
10-16	2048-2055	optimum	_	_	
10-17	2056-2067	stimulation	_	_	
10-18	2068-2076	settings	_	_	
10-19	2076-2077	,	_	_	
10-20	2078-2080	is	_	_	
10-21	2081-2082	a	_	_	
10-22	2083-2087	very	_	_	
10-23	2088-2095	lengthy	_	_	
10-24	2096-2099	and	_	_	
10-25	2100-2107	tedious	_	_	
10-26	2108-2115	process	_	_	
10-27	2115-2116	.	_	_	

#Text=Because an all-combination test is lengthy and tedious, some clinicians may not bother to test many different electrode combinations, including many that may be considered far more optimal than what is ultimately programmed for the patient.
11-1	2117-2124	Because	_	_	
11-2	2125-2127	an	_	_	
11-3	2128-2143	all-combination	_	_	
11-4	2144-2148	test	_	_	
11-5	2149-2151	is	_	_	
11-6	2152-2159	lengthy	_	_	
11-7	2160-2163	and	_	_	
11-8	2164-2171	tedious	_	_	
11-9	2171-2172	,	_	_	
11-10	2173-2177	some	_	_	
11-11	2178-2188	clinicians	_	_	
11-12	2189-2192	may	_	_	
11-13	2193-2196	not	_	_	
11-14	2197-2203	bother	_	_	
11-15	2204-2206	to	_	_	
11-16	2207-2211	test	_	_	
11-17	2212-2216	many	_	_	
11-18	2217-2226	different	_	_	
11-19	2227-2236	electrode	_	_	
11-20	2237-2249	combinations	_	_	
11-21	2249-2250	,	_	_	
11-22	2251-2260	including	_	_	
11-23	2261-2265	many	_	_	
11-24	2266-2270	that	_	_	
11-25	2271-2274	may	_	_	
11-26	2275-2277	be	_	_	
11-27	2278-2288	considered	_	_	
11-28	2289-2292	far	_	_	
11-29	2293-2297	more	_	_	
11-30	2298-2305	optimal	_	_	
11-31	2306-2310	than	_	_	
11-32	2311-2315	what	_	_	
11-33	2316-2318	is	_	_	
11-34	2319-2329	ultimately	_	_	
11-35	2330-2340	programmed	_	_	
11-36	2341-2344	for	_	_	
11-37	2345-2348	the	_	_	
11-38	2349-2356	patient	_	_	
11-39	2356-2357	.	_	_	

#Text=It is thus evident that there is a need in the art for a more manageable programming technique for testing and handling a large number of possible electrode and pulse parameter combinations.
#Text=[0013]One method that has recently been developed for simplifying the programming process is described in U.S.
12-1	2358-2360	It	_	_	
12-2	2361-2363	is	_	_	
12-3	2364-2368	thus	_	_	
12-4	2369-2376	evident	_	_	
12-5	2377-2381	that	_	_	
12-6	2382-2387	there	_	_	
12-7	2388-2390	is	_	_	
12-8	2391-2392	a	_	_	
12-9	2393-2397	need	_	_	
12-10	2398-2400	in	_	_	
12-11	2401-2404	the	_	_	
12-12	2405-2408	art	_	_	
12-13	2409-2412	for	_	_	
12-14	2413-2414	a	_	_	
12-15	2415-2419	more	_	_	
12-16	2420-2430	manageable	_	_	
12-17	2431-2442	programming	_	_	
12-18	2443-2452	technique	_	_	
12-19	2453-2456	for	_	_	
12-20	2457-2464	testing	_	_	
12-21	2465-2468	and	_	_	
12-22	2469-2477	handling	_	_	
12-23	2478-2479	a	_	_	
12-24	2480-2485	large	_	_	
12-25	2486-2492	number	_	_	
12-26	2493-2495	of	_	_	
12-27	2496-2504	possible	_	_	
12-28	2505-2514	electrode	_	_	
12-29	2515-2518	and	_	_	
12-30	2519-2524	pulse	_	_	
12-31	2525-2534	parameter	_	_	
12-32	2535-2547	combinations	_	_	
12-33	2547-2548	.	_	_	
12-34	2549-2550	[	_	_	
12-35	2550-2554	0013	_	_	
12-36	2554-2555	]	_	_	
12-37	2555-2558	One	_	_	
12-38	2559-2565	method	_	_	
12-39	2566-2570	that	_	_	
12-40	2571-2574	has	_	_	
12-41	2575-2583	recently	_	_	
12-42	2584-2588	been	_	_	
12-43	2589-2598	developed	_	_	
12-44	2599-2602	for	_	_	
12-45	2603-2614	simplifying	_	_	
12-46	2615-2618	the	_	_	
12-47	2619-2630	programming	_	_	
12-48	2631-2638	process	_	_	
12-49	2639-2641	is	_	_	
12-50	2642-2651	described	_	_	
12-51	2652-2654	in	_	_	
12-52	2655-2658	U.S	_	_	
12-53	2658-2659	.	_	_	

#Text=Pat.
13-1	2660-2663	Pat	_	_	
13-2	2663-2664	.	_	_	

#Text=No. 5,370,672, incorporated herein by reference.
14-1	2665-2667	No	_	_	
14-2	2667-2668	.	_	_	
14-3	2669-2678	5,370,672	_	_	
14-4	2678-2679	,	_	_	
14-5	2680-2692	incorporated	_	_	
14-6	2693-2699	herein	_	_	
14-7	2700-2702	by	_	_	
14-8	2703-2712	reference	_	_	
14-9	2712-2713	.	_	_	

#Text=The '672 patent describes a programming system where the patient interacts with the clinician's programmer.
15-1	2714-2717	The	_	_	
15-2	2718-2719	'	_	_	
15-3	2719-2722	672	_	_	
15-4	2723-2729	patent	_	_	
15-5	2730-2739	describes	_	_	
15-6	2740-2741	a	_	_	
15-7	2742-2753	programming	_	_	
15-8	2754-2760	system	_	_	
15-9	2761-2766	where	_	_	
15-10	2767-2770	the	_	_	
15-11	2771-2778	patient	_	_	
15-12	2779-2788	interacts	_	_	
15-13	2789-2793	with	_	_	
15-14	2794-2797	the	_	_	
15-15	2798-2809	clinician's	_	_	
15-16	2810-2820	programmer	_	_	
15-17	2820-2821	.	_	_	

#Text=More specifically, the '672 patent teaches a system wherein the patient identifies the pain site by "drawing" the pain site on a touch screen that displays an illustration of the human body.
16-1	2822-2826	More	_	_	
16-2	2827-2839	specifically	_	_	
16-3	2839-2840	,	_	_	
16-4	2841-2844	the	_	_	
16-5	2845-2846	'	_	_	
16-6	2846-2849	672	_	_	
16-7	2850-2856	patent	_	_	
16-8	2857-2864	teaches	_	_	
16-9	2865-2866	a	_	_	
16-10	2867-2873	system	_	_	
16-11	2874-2881	wherein	_	_	
16-12	2882-2885	the	_	_	
16-13	2886-2893	patient	_	_	
16-14	2894-2904	identifies	_	_	
16-15	2905-2908	the	_	_	
16-16	2909-2913	pain	_	_	
16-17	2914-2918	site	_	_	
16-18	2919-2921	by	_	_	
16-19	2922-2923	"	_	_	
16-20	2923-2930	drawing	_	_	
16-21	2930-2931	"	_	_	
16-22	2932-2935	the	_	_	
16-23	2936-2940	pain	_	_	
16-24	2941-2945	site	_	_	
16-25	2946-2948	on	_	_	
16-26	2949-2950	a	_	_	
16-27	2951-2956	touch	_	_	
16-28	2957-2963	screen	_	_	
16-29	2964-2968	that	_	_	
16-30	2969-2977	displays	_	_	
16-31	2978-2980	an	_	_	
16-32	2981-2993	illustration	_	_	
16-33	2994-2996	of	_	_	
16-34	2997-3000	the	_	_	
16-35	3001-3006	human	_	_	
16-36	3007-3011	body	_	_	
16-37	3011-3012	.	_	_	

#Text=After entering the patient's stimulation thresholds and associated tolerances into the system, the computer generates a recommended electrode configuration for that patient using algorithms based on spinal cord stimulation research.
17-1	3013-3018	After	_	_	
17-2	3019-3027	entering	_	_	
17-3	3028-3031	the	_	_	
17-4	3032-3041	patient's	_	_	
17-5	3042-3053	stimulation	_	_	
17-6	3054-3064	thresholds	_	_	
17-7	3065-3068	and	_	_	
17-8	3069-3079	associated	_	_	
17-9	3080-3090	tolerances	_	_	
17-10	3091-3095	into	_	_	
17-11	3096-3099	the	_	_	
17-12	3100-3106	system	_	_	
17-13	3106-3107	,	_	_	
17-14	3108-3111	the	_	_	
17-15	3112-3120	computer	_	_	
17-16	3121-3130	generates	_	_	
17-17	3131-3132	a	_	_	
17-18	3133-3144	recommended	_	_	
17-19	3145-3154	electrode	_	_	
17-20	3155-3168	configuration	_	_	
17-21	3169-3172	for	_	_	
17-22	3173-3177	that	_	_	
17-23	3178-3185	patient	_	_	
17-24	3186-3191	using	_	_	
17-25	3192-3202	algorithms	_	_	
17-26	3203-3208	based	_	_	
17-27	3209-3211	on	_	_	
17-28	3212-3218	spinal	_	_	
17-29	3219-3223	cord	_	_	
17-30	3224-3235	stimulation	_	_	
17-31	3236-3244	research	_	_	
17-32	3244-3245	.	_	_	

#Text=The patient responds to the resulting stimulation by drawing the amount of paresthesia coverage over the body illustration.
18-1	3246-3249	The	_	_	
18-2	3250-3257	patient	_	_	
18-3	3258-3266	responds	_	_	
18-4	3267-3269	to	_	_	
18-5	3270-3273	the	_	_	
18-6	3274-3283	resulting	_	_	
18-7	3284-3295	stimulation	_	_	
18-8	3296-3298	by	_	_	
18-9	3299-3306	drawing	_	_	
18-10	3307-3310	the	_	_	
18-11	3311-3317	amount	_	_	
18-12	3318-3320	of	_	_	
18-13	3321-3332	paresthesia	_	_	
18-14	3333-3341	coverage	_	_	
18-15	3342-3346	over	_	_	
18-16	3347-3350	the	_	_	
18-17	3351-3355	body	_	_	
18-18	3356-3368	illustration	_	_	
18-19	3368-3369	.	_	_	

#Text=If the drawing paresthesia site does not fully match the pain site, the system adjusts the recommendation, and the patient responds again to the new sense of paresthesia.
19-1	3370-3372	If	*[1]	20-1[2_1]	
19-2	3373-3376	the	*[1]	_	
19-3	3377-3384	drawing	*[1]	_	
19-4	3385-3396	paresthesia	*[1]	_	
19-5	3397-3401	site	*[1]	_	
19-6	3402-3406	does	*[1]	_	
19-7	3407-3410	not	*[1]	_	
19-8	3411-3416	fully	*[1]	_	
19-9	3417-3422	match	*[1]	_	
19-10	3423-3426	the	*[1]	_	
19-11	3427-3431	pain	*[1]	_	
19-12	3432-3436	site	*[1]	_	
19-13	3436-3437	,	*[1]	_	
19-14	3438-3441	the	*[1]	_	
19-15	3442-3448	system	*[1]	_	
19-16	3449-3456	adjusts	*[1]	_	
19-17	3457-3460	the	*[1]	_	
19-18	3461-3475	recommendation	*[1]	_	
19-19	3475-3476	,	*[1]	_	
19-20	3477-3480	and	*[1]	_	
19-21	3481-3484	the	*[1]	_	
19-22	3485-3492	patient	*[1]	_	
19-23	3493-3501	responds	*[1]	_	
19-24	3502-3507	again	*[1]	_	
19-25	3508-3510	to	*[1]	_	
19-26	3511-3514	the	*[1]	_	
19-27	3515-3518	new	*[1]	_	
19-28	3519-3524	sense	*[1]	_	
19-29	3525-3527	of	*[1]	_	
19-30	3528-3539	paresthesia	*[1]	_	
19-31	3539-3540	.	*[1]	_	

#Text=This process is repeated until the best-tested settings are reached.
#Text=[0014]Advantageously, the process described in the '672 patent effectively eliminates the manual selection of electrode combinations, and reduces the selection process to a reasonable testing of electrode/parameter combinations based on an extensive pre-organized set of rules for programming optimization and patient input.
20-1	3541-3545	This	*[2]	_	
20-2	3546-3553	process	*[2]	_	
20-3	3554-3556	is	_	_	
20-4	3557-3565	repeated	_	_	
20-5	3566-3571	until	_	_	
20-6	3572-3575	the	_	_	
20-7	3576-3587	best-tested	_	_	
20-8	3588-3596	settings	_	_	
20-9	3597-3600	are	_	_	
20-10	3601-3608	reached	_	_	
20-11	3608-3609	.	_	_	
20-12	3610-3611	[	_	_	
20-13	3611-3615	0014	_	_	
20-14	3615-3616	]	_	_	
20-15	3616-3630	Advantageously	_	_	
20-16	3630-3631	,	_	_	
20-17	3632-3635	the	_	_	
20-18	3636-3643	process	_	_	
20-19	3644-3653	described	_	_	
20-20	3654-3656	in	_	_	
20-21	3657-3660	the	_	_	
20-22	3661-3662	'	_	_	
20-23	3662-3665	672	_	_	
20-24	3666-3672	patent	_	_	
20-25	3673-3684	effectively	_	_	
20-26	3685-3695	eliminates	_	_	
20-27	3696-3699	the	_	_	
20-28	3700-3706	manual	_	_	
20-29	3707-3716	selection	_	_	
20-30	3717-3719	of	_	_	
20-31	3720-3729	electrode	_	_	
20-32	3730-3742	combinations	_	_	
20-33	3742-3743	,	_	_	
20-34	3744-3747	and	_	_	
20-35	3748-3755	reduces	_	_	
20-36	3756-3759	the	_	_	
20-37	3760-3769	selection	_	_	
20-38	3770-3777	process	_	_	
20-39	3778-3780	to	_	_	
20-40	3781-3782	a	_	_	
20-41	3783-3793	reasonable	_	_	
20-42	3794-3801	testing	_	_	
20-43	3802-3804	of	_	_	
20-44	3805-3814	electrode	_	_	
20-45	3814-3815	/	_	_	
20-46	3815-3824	parameter	_	_	
20-47	3825-3837	combinations	_	_	
20-48	3838-3843	based	_	_	
20-49	3844-3846	on	_	_	
20-50	3847-3849	an	_	_	
20-51	3850-3859	extensive	_	_	
20-52	3860-3873	pre-organized	_	_	
20-53	3874-3877	set	_	_	
20-54	3878-3880	of	_	_	
20-55	3881-3886	rules	_	_	
20-56	3887-3890	for	_	_	
20-57	3891-3902	programming	_	_	
20-58	3903-3915	optimization	_	_	
20-59	3916-3919	and	_	_	
20-60	3920-3927	patient	_	_	
20-61	3928-3933	input	_	_	
20-62	3933-3934	.	_	_	

#Text=Moreover, the physician/clinician is not directly controlling the programming session; rather, the patient provides the system with the feedback without the need for the physician or clinician to interpret the patient's sensations or empirically estimate changes required in stimulation parameters.
#Text=[0015]Disadvantageously, using the method described in the '672 patent, the patient must still test and respond to each of the chosen combinations and must depend upon the system recommendations, which system recommendations might exclude a possible optimal setting for that patient.
21-1	3935-3943	Moreover	_	_	
21-2	3943-3944	,	_	_	
21-3	3945-3948	the	_	_	
21-4	3949-3958	physician	_	_	
21-5	3958-3959	/	_	_	
21-6	3959-3968	clinician	_	_	
21-7	3969-3971	is	_	_	
21-8	3972-3975	not	_	_	
21-9	3976-3984	directly	_	_	
21-10	3985-3996	controlling	_	_	
21-11	3997-4000	the	_	_	
21-12	4001-4012	programming	_	_	
21-13	4013-4020	session	_	_	
21-14	4020-4021	;	_	_	
21-15	4022-4028	rather	_	_	
21-16	4028-4029	,	_	_	
21-17	4030-4033	the	_	_	
21-18	4034-4041	patient	_	_	
21-19	4042-4050	provides	_	_	
21-20	4051-4054	the	_	_	
21-21	4055-4061	system	_	_	
21-22	4062-4066	with	_	_	
21-23	4067-4070	the	_	_	
21-24	4071-4079	feedback	_	_	
21-25	4080-4087	without	_	_	
21-26	4088-4091	the	_	_	
21-27	4092-4096	need	_	_	
21-28	4097-4100	for	_	_	
21-29	4101-4104	the	_	_	
21-30	4105-4114	physician	_	_	
21-31	4115-4117	or	_	_	
21-32	4118-4127	clinician	_	_	
21-33	4128-4130	to	_	_	
21-34	4131-4140	interpret	_	_	
21-35	4141-4144	the	_	_	
21-36	4145-4154	patient's	_	_	
21-37	4155-4165	sensations	_	_	
21-38	4166-4168	or	_	_	
21-39	4169-4180	empirically	_	_	
21-40	4181-4189	estimate	_	_	
21-41	4190-4197	changes	_	_	
21-42	4198-4206	required	_	_	
21-43	4207-4209	in	_	_	
21-44	4210-4221	stimulation	_	_	
21-45	4222-4232	parameters	_	_	
21-46	4232-4233	.	_	_	
21-47	4234-4235	[	_	_	
21-48	4235-4239	0015	_	_	
21-49	4239-4240	]	_	_	
21-50	4240-4257	Disadvantageously	_	_	
21-51	4257-4258	,	_	_	
21-52	4259-4264	using	_	_	
21-53	4265-4268	the	_	_	
21-54	4269-4275	method	_	_	
21-55	4276-4285	described	_	_	
21-56	4286-4288	in	_	_	
21-57	4289-4292	the	_	_	
21-58	4293-4294	'	_	_	
21-59	4294-4297	672	_	_	
21-60	4298-4304	patent	_	_	
21-61	4304-4305	,	_	_	
21-62	4306-4309	the	_	_	
21-63	4310-4317	patient	_	_	
21-64	4318-4322	must	_	_	
21-65	4323-4328	still	_	_	
21-66	4329-4333	test	_	_	
21-67	4334-4337	and	_	_	
21-68	4338-4345	respond	_	_	
21-69	4346-4348	to	_	_	
21-70	4349-4353	each	_	_	
21-71	4354-4356	of	_	_	
21-72	4357-4360	the	_	_	
21-73	4361-4367	chosen	_	_	
21-74	4368-4380	combinations	_	_	
21-75	4381-4384	and	_	_	
21-76	4385-4389	must	_	_	
21-77	4390-4396	depend	_	_	
21-78	4397-4401	upon	_	_	
21-79	4402-4405	the	_	_	
21-80	4406-4412	system	_	_	
21-81	4413-4428	recommendations	_	_	
21-82	4428-4429	,	_	_	
21-83	4430-4435	which	_	_	
21-84	4436-4442	system	_	_	
21-85	4443-4458	recommendations	_	_	
21-86	4459-4464	might	_	_	
21-87	4465-4472	exclude	_	_	
21-88	4473-4474	a	_	_	
21-89	4475-4483	possible	_	_	
21-90	4484-4491	optimal	_	_	
21-91	4492-4499	setting	_	_	
21-92	4500-4503	for	_	_	
21-93	4504-4508	that	_	_	
21-94	4509-4516	patient	_	_	
21-95	4516-4517	.	_	_	

#Text=Further, the patient must be able to accurately translate subtle sensations and differences to a drawing on a screen, and then wait for device programming before having to react and redraw the paresthesia from the new settings.
22-1	4518-4525	Further	_	_	
22-2	4525-4526	,	_	_	
22-3	4527-4530	the	_	_	
22-4	4531-4538	patient	_	_	
22-5	4539-4543	must	_	_	
22-6	4544-4546	be	_	_	
22-7	4547-4551	able	_	_	
22-8	4552-4554	to	_	_	
22-9	4555-4565	accurately	_	_	
22-10	4566-4575	translate	_	_	
22-11	4576-4582	subtle	_	_	
22-12	4583-4593	sensations	_	_	
22-13	4594-4597	and	_	_	
22-14	4598-4609	differences	_	_	
22-15	4610-4612	to	_	_	
22-16	4613-4614	a	_	_	
22-17	4615-4622	drawing	_	_	
22-18	4623-4625	on	_	_	
22-19	4626-4627	a	_	_	
22-20	4628-4634	screen	_	_	
22-21	4634-4635	,	_	_	
22-22	4636-4639	and	_	_	
22-23	4640-4644	then	_	_	
22-24	4645-4649	wait	_	_	
22-25	4650-4653	for	_	_	
22-26	4654-4660	device	_	_	
22-27	4661-4672	programming	_	_	
22-28	4673-4679	before	_	_	
22-29	4680-4686	having	_	_	
22-30	4687-4689	to	_	_	
22-31	4690-4695	react	_	_	
22-32	4696-4699	and	_	_	
22-33	4700-4706	redraw	_	_	
22-34	4707-4710	the	_	_	
22-35	4711-4722	paresthesia	_	_	
22-36	4723-4727	from	_	_	
22-37	4728-4731	the	_	_	
22-38	4732-4735	new	_	_	
22-39	4736-4744	settings	_	_	
22-40	4744-4745	.	_	_	

#Text=Such process can still be time consuming.
23-1	4746-4750	Such	_	_	
23-2	4751-4758	process	_	_	
23-3	4759-4762	can	_	_	
23-4	4763-4768	still	_	_	
23-5	4769-4771	be	_	_	
23-6	4772-4776	time	_	_	
23-7	4777-4786	consuming	_	_	
23-8	4786-4787	.	_	_	

#Text=Furthermore, subtle sensation differences felt by the patient between combinations cannot necessarily be translated in a drawing of paresthesia that only address "coverage area."
24-1	4788-4799	Furthermore	_	_	
24-2	4799-4800	,	_	_	
24-3	4801-4807	subtle	_	_	
24-4	4808-4817	sensation	_	_	
24-5	4818-4829	differences	_	_	
24-6	4830-4834	felt	_	_	
24-7	4835-4837	by	_	_	
24-8	4838-4841	the	_	_	
24-9	4842-4849	patient	_	_	
24-10	4850-4857	between	_	_	
24-11	4858-4870	combinations	_	_	
24-12	4871-4877	cannot	_	_	
24-13	4878-4889	necessarily	_	_	
24-14	4890-4892	be	_	_	
24-15	4893-4903	translated	_	_	
24-16	4904-4906	in	_	_	
24-17	4907-4908	a	_	_	
24-18	4909-4916	drawing	_	_	
24-19	4917-4919	of	_	_	
24-20	4920-4931	paresthesia	_	_	
24-21	4932-4936	that	_	_	
24-22	4937-4941	only	_	_	
24-23	4942-4949	address	_	_	
24-24	4950-4951	"	_	_	
24-25	4951-4959	coverage	_	_	
24-26	4960-4964	area	_	_	
24-27	4964-4965	.	_	_	
24-28	4965-4966	"	_	_	

#Text=In summary, by reducing the combinations to a computer-generated recommendation, many electrode combinations might be omitted that could provide a more effective paresthesia.
25-1	4967-4969	In	_	_	
25-2	4970-4977	summary	_	_	
25-3	4977-4978	,	_	_	
25-4	4979-4981	by	_	_	
25-5	4982-4990	reducing	_	_	
25-6	4991-4994	the	_	_	
25-7	4995-5007	combinations	_	_	
25-8	5008-5010	to	_	_	
25-9	5011-5012	a	_	_	
25-10	5013-5031	computer-generated	_	_	
25-11	5032-5046	recommendation	_	_	
25-12	5046-5047	,	_	_	
25-13	5048-5052	many	_	_	
25-14	5053-5062	electrode	_	_	
25-15	5063-5075	combinations	_	_	
25-16	5076-5081	might	_	_	
25-17	5082-5084	be	_	_	
25-18	5085-5092	omitted	_	_	
25-19	5093-5097	that	_	_	
25-20	5098-5103	could	_	_	
25-21	5104-5111	provide	_	_	
25-22	5112-5113	a	_	_	
25-23	5114-5118	more	_	_	
25-24	5119-5128	effective	_	_	
25-25	5129-5140	paresthesia	_	_	
25-26	5140-5141	.	_	_	

#Text=Hence, the process of computer-recommended combinations, although superior to manual arbitrary selection, can still be viewed as an undesirable "discrete" method of patient feedback evaluation: i.e., electrodes are programmed and patient feedback is entered for each combination, one iteration at a time.
26-1	5142-5147	Hence	_	_	
26-2	5147-5148	,	_	_	
26-3	5149-5152	the	_	_	
26-4	5153-5160	process	_	_	
26-5	5161-5163	of	_	_	
26-6	5164-5184	computer-recommended	_	_	
26-7	5185-5197	combinations	_	_	
26-8	5197-5198	,	_	_	
26-9	5199-5207	although	_	_	
26-10	5208-5216	superior	_	_	
26-11	5217-5219	to	_	_	
26-12	5220-5226	manual	_	_	
26-13	5227-5236	arbitrary	_	_	
26-14	5237-5246	selection	_	_	
26-15	5246-5247	,	_	_	
26-16	5248-5251	can	_	_	
26-17	5252-5257	still	_	_	
26-18	5258-5260	be	_	_	
26-19	5261-5267	viewed	_	_	
26-20	5268-5270	as	_	_	
26-21	5271-5273	an	_	_	
26-22	5274-5285	undesirable	_	_	
26-23	5286-5287	"	_	_	
26-24	5287-5295	discrete	_	_	
26-25	5295-5296	"	_	_	
26-26	5297-5303	method	_	_	
26-27	5304-5306	of	_	_	
26-28	5307-5314	patient	_	_	
26-29	5315-5323	feedback	_	_	
26-30	5324-5334	evaluation	_	_	
26-31	5334-5335	:	_	_	
26-32	5336-5339	i.e	_	_	
26-33	5339-5340	.	_	_	
26-34	5340-5341	,	_	_	
26-35	5342-5352	electrodes	_	_	
26-36	5353-5356	are	_	_	
26-37	5357-5367	programmed	_	_	
26-38	5368-5371	and	_	_	
26-39	5372-5379	patient	_	_	
26-40	5380-5388	feedback	_	_	
26-41	5389-5391	is	_	_	
26-42	5392-5399	entered	_	_	
26-43	5400-5403	for	_	_	
26-44	5404-5408	each	_	_	
26-45	5409-5420	combination	_	_	
26-46	5420-5421	,	_	_	
26-47	5422-5425	one	_	_	
26-48	5426-5435	iteration	_	_	
26-49	5436-5438	at	_	_	
26-50	5439-5440	a	_	_	
26-51	5441-5445	time	_	_	
26-52	5445-5446	.	_	_	
